Search - tctmd.com

Displaying 41 - 60 of 213

Sort: Relevancy | Date

Presentation TVT 2022

Acurate Neo2: Update From the ACURATE IDE and Related Studies

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Avoiding PVL by Valve design in the Younger Patients

Presenter: Michael Reardon

June 08, 2022

Presentation TVT 2022

Hemodynamics and the Impact For Younger Patients

Presenter: Michael Reardon

June 08, 2022

Presentation TVT 2022

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Presenter: Michael J. Reardon

June 08, 2022

News Conference News ACC 2022

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Yael L. Maxwell

April 05, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

Presentation TCT 2021

DurAVR THV: A Novel 3D Single Piece Valve Designed for Improved Durability and Hemodynamics

Presenter: Samir Kapadia

November 05, 2021

News Daily News

TAVR Yields Similar Success in Failed TAVR or Surgical Valves

Caitlin E. Cox

January 07, 2021

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

Presenter: Michael Reardon

October 16, 2020

News Daily News

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

Michael O'Riordan

September 28, 2020

News Daily News

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Yael L. Maxwell

June 10, 2020

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

Presentation TCT 2019

Program Update: The ACURATE NEO TAVR System

Presenter: Michael Reardon

September 27, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Presenter: Michael Reardon

September 26, 2019

Presentation TCT 2019

Treatment of AS across the Spectrum of Risk

Presenter: Michael Reardon

September 25, 2019

Presentation TCT 2019

The Clinical Evidence: Extreme- to Low-Risk Patients

Presenter: Michael Reardon

September 25, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Industry News

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

August 16, 2019

News Daily News

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Shelley Wood

June 27, 2019

Advertisement

Acurate Neo2: Update From the ACURATE IDE and Related Studies

Avoiding PVL by Valve design in the Younger Patients

Hemodynamics and the Impact For Younger Patients

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

DurAVR THV: A Novel 3D Single Piece Valve Designed for Improved Durability and Hemodynamics

TAVR Yields Similar Success in Failed TAVR or Surgical Valves

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Program Update: The ACURATE NEO TAVR System

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Treatment of AS across the Spectrum of Risk

The Clinical Evidence: Extreme- to Low-Risk Patients

FDA Expands TAVR Indication to Low-Risk Patients

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content